Skip to main content
. 2016 Mar 11;12(3):e1004749. doi: 10.1371/journal.pcbi.1004749

Fig 5. Corresponding treatment outcomes after two rounds of identical six-month short course therapy.

Fig 5

(A) Treatment outcome probabilities after two rounds of identical first line therapy for treatment failure (blue), the emergence of MDR-TB (green) and the emergence of a fully resistant strain (FR, red). (B) Probabilities for patients who did not complete the first therapy successfully but who also did not harbor MDR-TB. (C) Treatment outcome probabilities for patients who failed the first treatment with MDR-TB. (D) The overall probabilities for treatment outcome when both treatment regimens are considered. There is no data available in panel (C) for patients with a lower adherence than 25% because such patients did not harbor MDR-TB after the first treatment.